Phase I/II Study Evaluating the Safety and Efficacy of Leuvectin Immunotherapy for the Treatment of Locally Recurrent Prostate Cancer Following Radiation Therapy
Phase of Trial: Phase I/II
Latest Information Update: 19 Aug 2014
At a glance
- Drugs Leuvectin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- Sponsors Vical
- 28 Jul 2014 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 28 Sep 2005 New trial record.